Form 4: Azenta Inc. Director Martin Madaus Acquires Shares in Open Market Transaction

Director Martin Madaus of Azenta, Inc. purchased 4,940 shares of common stock at an average price of $40.77 on November 19, 2024.

Summary

• On November 19, 2024, Martin Madaus, a director of Azenta, Inc., acquired 4,940 shares of the company's common stock.
• The shares were purchased at a weighted average price of $40.77 per share.
• The prices paid for the shares ranged from $40.59 to $40.90.
• Following this transaction, Mr. Madaus directly owns 7,405 shares of Azenta, Inc.

Sentiment

Score: 6

Explanation: The document is a neutral report of a stock purchase by a director. While insider buying can be seen as a positive signal, it's a routine transaction and doesn't necessarily indicate a significant shift in the company's outlook.

Positives

• The purchase of shares by a director can be seen as a positive sign of confidence in the company's future prospects.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade their company's stock. It provides transparency into the trading activities of company directors.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the United States, ensuring transparency of insider trading.
• The transaction is typical for directors who may buy or sell shares in their company, and the reporting is consistent with SEC regulations.
• Similar filings can be seen across all publicly listed companies in the US, such as those in the S&P 500, including companies like Thermo Fisher Scientific (TMO) and Danaher Corporation (DHR), which are in the same industry.

Stakeholder Impact

• The purchase of shares by a director may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Azenta Inc., insider trading, stock purchase, Martin Madaus, director, common stock, share acquisition